Lifevantage Corporation - Common Stock (LFVN)

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

LifeVantage (LFVN) reported mixed Q4 FY2025 results, beating EPS estimates at $0.17 but missing revenue forecasts. The stock fell sharply in after-hours trading.

When backtesting a portfolio strategy, you have to decide how far back to look. Should you use all available data, stretching back decades? Or should you just look at the last few years? There are arguments to be made for both options.

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

LFVN stock results show that Lifevantage beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.

Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.